https://www.thebodypro.com/category/providing-quality-hiv-care/tag/id-week

The Latest

Promo Image

A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017

Highlights of major findings on new antiretroviral therapies, including data on long-acting injectable solutions and new combination treatments packed into a single pill.

Joseph Eron Jr., M.D.

If at First an HIV Viral Load Blips, Test, Test (the Same Sample) Again

If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., recommends. New study results suggest that the retest results may alter a clinicia...

Gretchen Volpe, M.D., M.P.H.

Over Time, High-Dose Omega-3 May Improve Some Cardiovascular Measures in People With HIV

High-dose, long-term omega-3 supplementation appears to yield improved triglycerides and C-reactive protein levels among HIV-positive people who have elevated triglycerides, but only after more than a year of use, a new study has found.

CD4 Nadir Not a Predictor of Pneumonia After Starting HIV Treatment, Study Finds Img

CD4 Nadir Not a Predictor of Pneumonia After Starting HIV Treatment, Study Finds

People with HIV face an increased pneumonia risk even after they've started HIV treatment. However, a recent study suggests that risk isn't affected by how suppressed the immune system was prior to starting treatment.